Dytfeld D, Costa L, Oriol A, Manier S, Voorhees P, Lin Y, Htut M, Roeloffzen W, Ho PJ, Shah U, Zhao M, Li Q, Balogh A, Li K, Slaughter A, Benachour N, Lonardi C, Ghosh A, Sun H, Lendvai N, Lengil T, Patel N, Koneru M, Florendo E, Filho OC, Mahajan V, Rodríguez-Otero P, Strouse C, Stewart A, Sidana S. P48 | LONG-TERM PROGRESSION-FREE SURVIVAL BENEFIT WITH CILTACABTAGENE AUTOLEUCEL IN STANDARD-RISK RELAPSED/REFRACTORY MULTIPLE MYELOMA. haematol [Internet]. 2026Apr.15 [cited 2026Apr.21];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14061